{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:08:01Z","timestamp":1793203681260,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["312326\/Z\/24\/Z"],"award-info":[{"award-number":["312326\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["312326\/Z\/24\/Z"],"award-info":[{"award-number":["312326\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["312326\/Z\/24\/Z"],"award-info":[{"award-number":["312326\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["312326\/Z\/24\/Z"],"award-info":[{"award-number":["312326\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["312326\/Z\/24\/Z"],"award-info":[{"award-number":["312326\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The Zanzibar islands have implemented mass drug administration (MDA) with praziquantel against\n                      <jats:italic>Schistosoma haematobium<\/jats:italic>\n                      infections since the 2000s, achieving elimination of schistosomiasis as a public health problem in most areas. However, a few hotspots with high prevalence of infection remain, where MDA-driven selection of drug-resistance within the\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      populations might contribute to persistent transmission. Recent advances in understanding the molecular basis of praziquantel action on the\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      transient receptor potential ion channel (TRPM\n                      <jats:sub>PZQ<\/jats:sub>\n                      ) now facilitate screening\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      populations for genetic signatures that may point to reduced praziquantel efficacy, or even resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This observational study is implemented from 2024 to 2027 and contains four components: (1) Cross-sectional surveys in Pemba: Single urine samples are collected from ~\u200914,400 students across 15 schools to assess the geographic distribution of\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      infection prevalence and intensity, and for miracidia collection. (2) Longitudinal studies in Pemba: Quintuple urine samples are collected from ~\u2009945 students across two schools before and two weeks after MDA to assess\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      egg reduction rates (ERR), and for miracidia collection. (3) Genome-wide analyses of the\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      miracidia collected in 1 and 2, (a) across Pemba over multiple time points (including archived specimens collected in 2012 and 2017) to quantify spatiotemporal patterns of parasite genetic variation; and (b) before and two weeks after MDA to identify any genetic variants under selection and potentially associated with praziquantel sensitivity. 4) Modelling to: (a) analyse correlation of observed\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      ERR and miracidia genetic profiles; (b) predict the impact of MDA and mitigation strategies on emergence of drug resistance; and (c) design cost-efficient survey strategies for pharmacovigilance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      The combination of parasitological fieldwork, genomic analyses, and mathematical modelling will deliver new insights into how MDA has shaped genetic diversity of\n                      <jats:italic>S. haematobium<\/jats:italic>\n                      populations, how this might affect drug efficacy and contribute to persistent hotspots, and how this can best be monitored and mitigated. This project will lay the foundations for population-based research into drug resistance in\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      with important implications for novel drugs in the pipeline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ISRCTN, ISRCTN59331501. Registered 24 October 2024,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN59331501\" ext-link-type=\"uri\">https:\/\/www.isrctn.com\/ISRCTN59331501<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12474-1","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:47:38Z","timestamp":1767869258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Resistance evaluation and surveillance initiative for schistosomiasis treatment: study protocol for the RESIST project"],"prefix":"10.1186","volume":"26","author":[{"given":"Stefanie","family":"Knopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan M.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pennance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie L.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc E.","family":"Coffeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"12474_CR1","unstructured":"WHO: Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030. Geneva. 2021:196."},{"issue":"10479","key":"12474_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(24)02814-9","volume":"405","author":"D Buonfrate","year":"2025","unstructured":"Buonfrate D, Ferrari TCA, Adegnika AA, Russell Stothard J, Gobbi FG. Human schistosomiasis. Lancet. 2025;405(10479):658\u201370.","journal-title":"Lancet"},{"key":"12474_CR3","unstructured":"WHO. WHO guideline on control and elimination of human schistosomiasis. Geneva. 2022:144."},{"issue":"1","key":"12474_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1473-3099(21)00090-6","volume":"22","author":"C Kokaliaris","year":"2022","unstructured":"Kokaliaris C, Garba A, Matuska M, Bronzan RN, Colley DG, Dorkenoo AM, Ekpo UF, Fleming FM, French MD, Kabore A, Mbonigaba JB, Midzi N, Mwinzi PNM, N\u2019Goran EK, Polo MR, Sacko M, Tchuem Tchuente LA, Tukahebwa EM, Uvon PA, Yang G, Wiesner L, Zhang Y, Utzinger J, Vounatsou P. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan africa: a Spatiotemporal modelling study. Lancet Infect Dis. 2022;22(1):136\u201349.","journal-title":"Lancet Infect Dis"},{"key":"12474_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.apar.2023.06.001","volume":"122","author":"L Trippler","year":"2023","unstructured":"Trippler L, Knopp S, Welsche S, Webster BL, Stothard JR, Blair L, Allan F, Ame SM, Juma S, Kabole F, Ali SM, Rollinson D, Pennance T. The long road to schistosomiasis elimination in zanzibar: A systematic review covering 100 years of research, interventions and control milestones. Adv Parasitol. 2023;122:71\u2013191.","journal-title":"Adv Parasitol"},{"issue":"6","key":"12474_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0035-9203(89)90336-2","volume":"83","author":"L Savioli","year":"1989","unstructured":"Savioli L, Dixon H, Kisumku UM, Mott KE. Control of morbidity due to Schistosoma haematobium on Pemba island; selective population chemotherapy of schoolchildren with haematuria to identify high-risk localities. Trans R Soc Trop Med Hyg. 1989;83(6):805\u201310.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"12474_CR7","doi-asserted-by":"publisher","first-page":"e0007268","DOI":"10.1371\/journal.pntd.0007268","volume":"13","author":"S Knopp","year":"2019","unstructured":"Knopp S, Ame SM, Person B, Hattendorf J, Rabone M, Juma S, Muhsin J, Khamis IS, Hollenberg E, Mohammed KA, Kabole F, Ali SM, Rollinson D. A 5-Year intervention study on elimination of urogenital schistosomiasis in zanzibar: parasitological results of annual cross-sectional surveys. PLoS Negl Trop Dis. 2019;13(5):e0007268.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"12474_CR8","doi-asserted-by":"publisher","first-page":"e1118","DOI":"10.1016\/S2214-109X(19)30189-5","volume":"7","author":"S Knopp","year":"2019","unstructured":"Knopp S, Person B, Ame SM, Ali SM, Hattendorf J, Juma S, Muhsin J, Khamis IS, Mohammed KA, Utzinger J, Hollenberg E, Kabole F, Rollinson D. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial. Lancet Global Health. 2019;7(8):e1118\u201329.","journal-title":"Lancet Global Health"},{"issue":"2","key":"12474_CR9","doi-asserted-by":"publisher","first-page":"e0009127","DOI":"10.1371\/journal.pntd.0009127","volume":"15","author":"L Trippler","year":"2021","unstructured":"Trippler L, Ame SM, Hattendorf J, Juma S, Abubakar S, Ali SM, Kabole F, Rollinson D, Knopp S. Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in zanzibar: repeated cross-sectional studies. PLoS Negl Trop Dis. 2021;15(2):e0009127.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"12474_CR10","doi-asserted-by":"publisher","first-page":"e0013079","DOI":"10.1371\/journal.pntd.0013079","volume":"19","author":"L Trippler","year":"2025","unstructured":"Trippler L, Ali SM, Ali MN, Mohammed UA, Suleiman KR, Ndum NC, Juma S, Ame SM, Kabole F, Hattendorf J, Knopp S. Adaptive integrated intervention approaches for schistosomiasis elimination in pemba: A 4-year intervention study and focus on hotspots. PLoS Negl Trop Dis. 2025;19(6):e0013079.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"12474_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1186\/s13071-016-1847-0","volume":"9","author":"T Pennance","year":"2016","unstructured":"Pennance T, Person B, Muhsin MA, Khamis AN, Muhsin J, Khamis IS, Mohammed KA, Kabole F, Rollinson D, Knopp S. Urogenital schistosomiasis transmission on Unguja Island, Zanzibar: characterisation of persistent hot-spots. Parasit Vectors. 2016;9(1):646.","journal-title":"Parasit Vectors"},{"issue":"1","key":"12474_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpddr.2011.09.002","volume":"1","author":"J Vercruysse","year":"2011","unstructured":"Vercruysse J, Albonico M, Behnke JM, Kotze AC, Prichard RK, McCarthy JS, Montresor A, Levecke B. Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol Drugs Drug Resist. 2011;1(1):14\u201327.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"5","key":"12474_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1021\/acsinfecdis.3c00081","volume":"9","author":"N Caldwell","year":"2023","unstructured":"Caldwell N, Afshar R, Baragana B, Bustinduy AL, Caffrey CR, Collins JJ, Fusco D, Garba A, Gardner M, Gomes M, Hoffmann KF, Hsieh M, Lo NC, McNamara CW, Nono JK, Padalino G, Read KD, Roestenberg M, Spangenberg T, Specht S, Gilbert IH. Perspective on schistosomiasis drug discovery: highlights from a schistosomiasis drug discovery workshop at Wellcome Collection, London, September 2022. ACS Infect Dis. 2023;9(5):1046\u201355.","journal-title":"ACS Infect Dis"},{"issue":"1","key":"12474_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41467-024-45027-2","volume":"15","author":"LE Coffeng","year":"2024","unstructured":"Coffeng LE, Stolk WA, de Vlas SJ. Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy. Nat Commun. 2024;15(1):1099.","journal-title":"Nat Commun"},{"issue":"49","key":"12474_CR15","doi-asserted-by":"publisher","first-page":"18873","DOI":"10.1074\/jbc.AC119.011093","volume":"294","author":"SK Park","year":"2019","unstructured":"Park SK, Gunaratne GS, Chulkov EG, Moehring F, McCusker P, Dosa PI, Chan JD, Stucky CL, Marchant JS. The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel. J Biol Chem. 2019;294(49):18873\u201380.","journal-title":"J Biol Chem"},{"issue":"625","key":"12474_CR16","doi-asserted-by":"publisher","first-page":"eabj5832","DOI":"10.1126\/scitranslmed.abj5832","volume":"13","author":"SK Park","year":"2021","unstructured":"Park SK, Friedrich L, Yahya NA, Rohr CM, Chulkov EG, Maillard D, Rippmann F, Spangenberg T, Marchant JS. Mechanism of praziquantel action at a parasitic flatworm ion channel. Sci Transl Med. 2021;13(625):eabj5832.","journal-title":"Sci Transl Med"},{"issue":"625","key":"12474_CR17","doi-asserted-by":"publisher","first-page":"eabj9114","DOI":"10.1126\/scitranslmed.abj9114","volume":"13","author":"W Le Clec\u2019h","year":"2021","unstructured":"Le Clec\u2019h W, Chevalier FD, Mattos ACA, Strickland A, Diaz R, McDew-White M, Rohr CM, Kinung\u2019hi S, Allan F, Webster BL, Webster JP, Emery AM, Rollinson D, Djirmay AG, Al Mashikhi KM, Al Yafae S, Idris MA, Mone H, Mouahid G, LoVerde P, Marchant JS, Anderson TJC. Genetic analysis of praziquantel response in schistosome parasites implicates a transient receptor potential channel. Sci Transl Med. 2021;13(625):eabj9114.","journal-title":"Sci Transl Med"},{"issue":"3","key":"12474_CR18","doi-asserted-by":"publisher","first-page":"e0143223","DOI":"10.1128\/aac.01432-23","volume":"68","author":"FD Chevalier","year":"2024","unstructured":"Chevalier FD, Le Clec\u2019h W, Berriman M, Anderson TJ. A single locus determines praziquantel response in Schistosoma mansoni. Antimicrob Agents Chemother. 2024;68(3):e0143223.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12474_CR19","doi-asserted-by":"publisher","first-page":"e2217732120","DOI":"10.1073\/pnas.2217732120","volume":"120","author":"CM Rohr","year":"2023","unstructured":"Rohr CM, Sprague DJ, Park SK, Malcolm NJ, Marchant JS. Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity. Proc Natl Acad Sci USA. 2023;120(1):e2217732120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"12474_CR20","doi-asserted-by":"publisher","first-page":"e0011929","DOI":"10.1371\/journal.pntd.0011929","volume":"18","author":"JS Marchant","year":"2024","unstructured":"Marchant JS. Progress interrogating TRPMPZQ as the target of praziquantel. PLoS Negl Trop Dis. 2024;18(2):e0011929.","journal-title":"PLoS Negl Trop Dis"},{"key":"12474_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1756-3305-5-185","volume":"5","author":"AM Emery","year":"2012","unstructured":"Emery AM, Allan FE, Rabone ME, Rollinson D. Schistosomiasis collection at NHM (SCAN). Parasit Vectors. 2012;5:185.","journal-title":"Parasit Vectors"},{"issue":"Suppl 3","key":"12474_CR22","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1093\/cid\/ciab196","volume":"72","author":"LE Coffeng","year":"2021","unstructured":"Coffeng LE, Levecke B, Hattendorf J, Walker M, Denwood MJ. Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis. Clin Infect Dis. 2021;72(Suppl 3):S195\u2013202.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12474_CR23","doi-asserted-by":"publisher","first-page":"e0011071","DOI":"10.1371\/journal.pntd.0011071","volume":"17","author":"LE Coffeng","year":"2023","unstructured":"Coffeng LE, Vlaminck J, Cools P, Denwood M, Albonico M, Ame SM, Ayana M, Dana D, Cringoli G, de Vlas SJ, Fenwick A, French M, Kazienga A, Keiser J, Knopp S, Leta G, Matoso LF, Maurelli MP, Montresor A, Mirams G, Mekonnen Z, Correa-Oliveira R, Pinto SA, Rinaldi L, Sayasone S, Steinmann P, Thomas E, Vercruysse J, Levecke B. A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs-monitoring of therapeutic drug efficacy as a case study. PLoS Negl Trop Dis. 2023;17(5):e0011071.","journal-title":"PLoS Negl Trop Dis"},{"key":"12474_CR24","doi-asserted-by":"publisher","first-page":"109867","DOI":"10.1016\/j.vetpar.2022.109867","volume":"314","author":"MJ Denwood","year":"2023","unstructured":"Denwood MJ, Kaplan RM, McKendrick IJ, Thamsborg SM, Nielsen MK, Levecke B. A statistical framework for calculating prospective sample sizes and classifying efficacy results for faecal egg count reduction tests in ruminants, horses and swine. Vet Parasitol. 2023;314:109867.","journal-title":"Vet Parasitol"},{"key":"12474_CR25","doi-asserted-by":"crossref","unstructured":"Berger DJ, Park SK, Crellen T, Vianney TJ, Kabatereine NB, Cotton JA, Sanya R, Elliot A, Tukahebwa EM, Adriko M, Standley CJ, Gouvras A, Kinung\u2019hi S, Haas H, Rabone M, Emery A, Lamberton PHL, Webster BL, Allan F, Buddenborg S, Berriman M, Marchant JS, Doyle SR, Webster JP. Extensive transmission and variation in a functional receptor for praziquantel resistance in endemic Schistosoma mansoni. bioRxiv 2024.","DOI":"10.1101\/2024.08.29.610291"},{"key":"12474_CR26","unstructured":"Rohr CM, Park SK, Aguiar-Martins K, Anderson TJC, Berger DJ, Berriman M, Buddenborg SK, Bustinduy AL, Chevalier FD, Cotton JA, Crellen T, Doyle SR, Emery AM, Smith JK, Kinung\u2019hi S, Lamberton PHL, Le Clec\u2019h W, Ndombi E, Pennance T, Rowel C, Summers SS, Tushabe JV, Walker M, Webster BL, Webster JP, Wilson S, Marchant JS. TRPtracker: a community database for monitoring praziquantel sensitivity at TRPM(PZQ) variants. bioRxiv 2025."},{"issue":"1","key":"12474_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/1471-2458-12-930","volume":"12","author":"S Knopp","year":"2012","unstructured":"Knopp S, Mohammed KA, Ali SM, Khamis IS, Ame SM, Albonico M, Gouvras A, Fenwick A, Savioli L, Colley DG, Utzinger J, Person B, Rollinson D. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health. 2012;12(1):930.","journal-title":"BMC Public Health"},{"issue":"5","key":"12474_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0035-9203(01)90034-3","volume":"95","author":"A Montresor","year":"2001","unstructured":"Montresor A, Engels D, Chitsulo L, Bundy DAP, Brooker S, Savioli L. Development and validation of a \u2018tablet pole\u2019 for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001;95(5):542\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"12474_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13071-015-1134-5","volume":"8","author":"BL Webster","year":"2015","unstructured":"Webster BL, Rabone M, Pennance T, Emery AM, Allan F, Gouvras A, Knopp S, Garba A, Hamidou AA, Mohammed KA, Ame SM, Rollinson D, Webster JP. Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium. Parasit Vectors. 2015;8:519.","journal-title":"Parasit Vectors"},{"issue":"13","key":"12474_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1017\/S0031182018000811","volume":"145","author":"W Le Clec\u2019h","year":"2018","unstructured":"Le Clec\u2019h W, Chevalier FD, McDew-White M, Allan F, Webster BL, Gouvras AN, Kinunghi S, Tchuem Tchuente LA, Garba A, Mohammed KA, Ame SM, Webster JP, Rollinson D, Emery AM, Anderson TJC. Whole genome amplification and exome sequencing of archived schistosome miracidia. Parasitology. 2018;145(13):1739\u201347.","journal-title":"Parasitology"},{"issue":"1","key":"12474_CR31","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1038\/s41467-021-24958-0","volume":"12","author":"DJ Berger","year":"2021","unstructured":"Berger DJ, Crellen T, Lamberton PHL, Allan F, Tracey A, Noonan JD, Kabatereine NB, Tukahebwa EM, Adriko M, Holroyd N, Webster JP, Berriman M, Cotton JA. Whole-genome sequencing of schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration. Nat Commun. 2021;12(1):4776.","journal-title":"Nat Commun"},{"issue":"2","key":"12474_CR32","doi-asserted-by":"publisher","first-page":"e1010288","DOI":"10.1371\/journal.ppat.1010288","volume":"18","author":"AJ Stroehlein","year":"2022","unstructured":"Stroehlein AJ, Korhonen PK, Lee VV, Ralph SA, Mentink-Kane M, You H, McManus DP, Tchuente LT, Stothard JR, Kaur P, Dudchenko O, Aiden EL, Yang B, Yang H, Emery AM, Webster BL, Brindley PJ, Rollinson D, Chang BCH, Gasser RB, Young ND. Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variation. PLoS Pathog. 2022;18(2):e1010288.","journal-title":"PLoS Pathog"},{"issue":"2","key":"12474_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM. A program for annotating and predicting the effects of single nucleotide polymorphisms, snpeff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80\u201392.","journal-title":"Fly (Austin)"},{"issue":"4","key":"12474_CR34","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/1755-0998.13326","volume":"21","author":"KL Korunes","year":"2021","unstructured":"Korunes KL, Samuk K. Pixy: unbiased Estimation of nucleotide diversity and divergence in the presence of missing data. Mol Ecol Resour. 2021;21(4):1359\u201368.","journal-title":"Mol Ecol Resour"},{"key":"12474_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"issue":"9","key":"12474_CR36","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1101\/gr.094052.109","volume":"19","author":"DH Alexander","year":"2009","unstructured":"Alexander DH, Novembre J, Lange K. Fast model-based Estimation of ancestry in unrelated individuals. Genome Res. 2009;19(9):1655\u201364.","journal-title":"Genome Res"},{"issue":"2","key":"12474_CR37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1534\/genetics.108.092221","volume":"180","author":"M Foll","year":"2008","unstructured":"Foll M, Gaggiotti O. A genome-scan method to identify selected loci appropriate for both dominant and codominant markers: a bayesian perspective. Genetics. 2008;180(2):977\u201393.","journal-title":"Genetics"},{"issue":"8","key":"12474_CR38","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/bioinformatics\/bts115","volume":"28","author":"M Gautier","year":"2012","unstructured":"Gautier M, Vitalis R. Rehh: an R package to detect footprints of selection in genome-wide SNP data from haplotype structure. Bioinformatics. 2012;28(8):1176\u20137.","journal-title":"Bioinformatics"},{"key":"12474_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpddr.2020.10.003","volume":"14","author":"B Levecke","year":"2020","unstructured":"Levecke B, Vlaminck J, Andriamaro L, Ame S, Belizario V, Degarege A, Engels D, Erko B, Garba AD, Kaatano GM, Mekonnen Z, Montresor A, Olliaro P, Pieri OS, Sacko M, Sam-Wobo SO, Tchuem Tchuente LA, Webster JP, Vercruysse J. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs. Int J Parasitol Drugs Drug Resist. 2020;14:183\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"12","key":"12474_CR40","doi-asserted-by":"publisher","first-page":"e0006758","DOI":"10.1371\/journal.pntd.0006758","volume":"12","author":"LE Coffeng","year":"2018","unstructured":"Coffeng LE, Vaz Nery S, Gray DJ, Bakker R, de Vlas SJ, Clements ACA. Predicted short and long-term impact of deworming and water, hygiene, and sanitation on transmission of soil-transmitted helminths. PLoS Negl Trop Dis. 2018;12(12):e0006758.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"12474_CR41","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.4269\/ajtmh.20-0252","volume":"103","author":"P Salari","year":"2020","unstructured":"Salari P, F\u00fcrst T, Knopp S, Rollinson D, Kabole F, Khamis MI, Omar MA, Bacon O, Ali SM, Utzinger J, Tediosi F. Financial costs of the Zanzibar elimination of schistosomiasis transmission project. Am J Trop Med Hyg. 2020;103(6):2260\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"12474_CR42","doi-asserted-by":"publisher","first-page":"e0008098","DOI":"10.1371\/journal.pntd.0008098","volume":"14","author":"P Salari","year":"2020","unstructured":"Salari P, F\u00fcrst T, Knopp S, Utzinger J, Tediosi F. Cost of interventions to control schistosomiasis: A systematic review of the literature. PLoS Negl Trop Dis. 2020;14(3):e0008098.","journal-title":"PLoS Negl Trop Dis"},{"key":"12474_CR43","unstructured":"WHO. Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases. In. Edited by Organization WH. Geneva: World Health Organization; 2013."},{"issue":"9","key":"12474_CR44","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12474-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:18:36Z","timestamp":1781626716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12474"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12474-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol has received ethical approval by the two independent ethics committees: (i) the ethics committee of northwestern and central Switzerland (Ethikkommission Nordwest- und Zentralschweiz; EKNZ) on August 13, 2024 (AO _2024-00084) and (ii) the Zanzibar Health Research Institute (ZAHRI) on September 24, 2024 (ZAHREC\/01\/PR\/\/Sept\/2024\/33). Only children who submit a written ICF signed by their care giver and an additional written assent form with their own signature (if aged 12\u201316 years), will be included in the study. The study will be carried out in accordance with principles enunciated in the current version of the Declaration of Helsinki \u201c2024\u201d. The trial was prospectively registered at ISRCTN (ISCRCTN59331501).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}